MARTINI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.715
EU - Europa 2.390
AS - Asia 1.215
SA - Sud America 147
Continente sconosciuto - Info sul continente non disponibili 47
AF - Africa 40
OC - Oceania 23
Totale 7.577
Nazione #
US - Stati Uniti d'America 3.644
RU - Federazione Russa 705
PL - Polonia 452
IT - Italia 419
SG - Singapore 327
CN - Cina 262
HK - Hong Kong 215
SE - Svezia 203
IE - Irlanda 169
VN - Vietnam 141
BR - Brasile 118
DE - Germania 100
KR - Corea 90
UA - Ucraina 85
FR - Francia 70
FI - Finlandia 65
GB - Regno Unito 58
IN - India 58
CA - Canada 47
JP - Giappone 25
AU - Australia 23
JO - Giordania 21
TR - Turchia 18
BE - Belgio 16
BD - Bangladesh 12
NL - Olanda 12
AR - Argentina 11
CI - Costa d'Avorio 10
MX - Messico 10
NG - Nigeria 9
RO - Romania 9
IQ - Iraq 8
VE - Venezuela 7
ID - Indonesia 6
PH - Filippine 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
PK - Pakistan 5
ZA - Sudafrica 5
ES - Italia 4
SC - Seychelles 4
CO - Colombia 3
HU - Ungheria 3
JM - Giamaica 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
SA - Arabia Saudita 3
SN - Senegal 3
AT - Austria 2
BG - Bulgaria 2
DZ - Algeria 2
EU - Europa 2
HN - Honduras 2
KZ - Kazakistan 2
PE - Perù 2
PR - Porto Rico 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LY - Libia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 7.532
Città #
Santa Clara 836
Warsaw 449
Ashburn 413
Fairfield 304
Chandler 253
Singapore 238
Hong Kong 179
Dublin 168
Jacksonville 132
Woodbridge 126
Seattle 116
Cambridge 115
Wilmington 99
Ann Arbor 94
Houston 93
Seoul 88
San Jose 84
Beijing 73
Milan 72
Los Angeles 58
Rome 53
Buffalo 50
The Dalles 43
Boston 42
Princeton 42
Ho Chi Minh City 40
Mumbai 37
Lauterbourg 36
Altamura 34
Dallas 34
Hanoi 31
Munich 31
Lawrence 29
Paris 27
Boardman 26
New York 25
Hefei 23
Melbourne 23
Tokyo 23
Phoenix 20
Falls Church 19
Shanghai 19
Council Bluffs 18
Brussels 16
Florence 16
Moscow 16
Montreal 14
Medford 12
Turku 12
Bologna 11
San Diego 11
Abidjan 10
Dearborn 10
Izmir 10
Toronto 10
Abuja 9
Denver 9
Helsinki 9
Hillsboro 9
Kent 9
London 9
Naples 9
São Paulo 9
Turin 9
Verona 9
Brooklyn 8
Chicago 8
Dong Ket 8
Figino 8
Haiphong 8
San Francisco 8
Tianjin 8
Venice 8
Amsterdam 7
Bari 7
Da Nang 7
Palermo 7
Brescia 6
Frankfurt Am Main 6
Norwalk 6
Orem 6
Ankara 5
Kochi 5
Miano 5
Washington 5
Auburn Hills 4
Belo Horizonte 4
Biên Hòa 4
Chennai 4
Curitiba 4
Edinburgh 4
Frankfurt am Main 4
Jakarta 4
Piscataway 4
Poplar 4
Rio de Janeiro 4
West Jordan 4
Yubileyny 4
Andover 3
Budapest 3
Totale 5.147
Nome #
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 412
Design, synthesis and binding affinity of new nicotinic ligands 352
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition-enhancers 315
DESIGN, SYNTHESIS AND PRELIMINARY PHARMACOLOGICAL EVALUATION OF RIGID ANALOGUES OF THE NICOTINIC AGONIST 1,1-DIMETHYL-4-PHENYLPIPERAZINIUM IODIDE (DMPP) 293
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND AFFINITY PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIO-ACETIC ACID ESTERS DESIGNED TO PROBE THE BINDING SITE CAVITY 262
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 245
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 214
Central Nicotinic receptors: structure, function, ligands, and therapeutic potential 213
Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands 213
2-PYRROLIDINONE MOIETY IS NOT CRITICAL FOR THE COGNITION ENHANCING ACTIVITY OF PIRACETAM-LIKE DRUGS 211
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 208
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 208
COGNITION-ENHANCING DRUGS IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD): AN UPDATE[1] 207
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. 205
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 204
Design, synthesis and pharmacological evaluation of some frozen-analogues of DMPP 186
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers 182
Design of novel nicotinic ligands through 3D database searching 179
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators. 174
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators 173
[35S]GTPgammaS binding studies of amphiphilic drugs-activated Gi proteins: A caveat 165
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent 164
Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs 154
Modulazione molecolare di antagonisti muscarinici. Sintesi e valutazione farmacologica preliminare di esteri amminoalchil piperazinici e piperidinici dell'acido 2,2-difenil-2-etiltioacetico 152
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs 148
Synthesis and Biological Evaluation of 3,7-Diazabicyclo[4.3.0]2 nonan-8-ones as Potential Nootropic and Analgesic Drugs 148
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 148
Design, synthesis and preliminary pharmacological evaluation of 1,4-diaminobenzenes and 1,4-diaminocyclohexanes as cognition modulators 146
DM232 and DM235, two potent cognition-enhancers, increase NO levels in rat adipocytes 142
Metodo per rimuovere un gruppo protettivo di un composto tetrazolico N-protetto 136
Highly chiral muscarinic ligands: synthesis and affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 136
Design, synthesis and pharmacological evaluation of novel analogues of the two nootropics unifiram (DM232) and sunifiram (DM235) 131
Sintesi e valutazione farmacologica di derivati furanici e tetraidrofuranici a potenziale azione muscarinica 129
synthesis, chiral HPLC separation and pharmacological characterization of muscarinic furan derivatives 129
Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs 128
Rigid Analogs of DMPP As Probes For The Nicotinic Receptors 126
Synthesis and pharmacological evaluation of new nicotinic ligands carrying a quinoline nucleus 118
Synthesis and pharmacological characterization of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 114
Intermediate compounds for the preparation of angiotensin II antagonists 113
Sintesi chirale e valutazione farmacologica preliminare degli enantiomeri di DM232 e MC68, due azabiciclononanoni modulatori dei processi cognitivi 104
Molecular simplification of DM232 and DM235, two new potent cognition enhancers 100
Progettazione, sintesi e valutazione farmacologica preliminare di analoghi strutturali di Sunifiram e Sapunifiram, due potemti agenti nootropi 90
Totale 7.577
Categoria #
all - tutte 19.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 16 46 30 5 9 18 23 11 10 13 73 74
2022/2023857 70 144 30 94 54 161 109 65 90 5 30 5
2023/2024308 11 30 46 13 17 57 9 85 5 6 10 19
2024/20252.042 55 212 126 280 649 348 13 124 54 57 64 60
2025/20261.970 245 280 134 107 240 93 246 68 126 112 38 281
2026/202761 61 0 0 0 0 0 0 0 0 0 0 0
Totale 7.577